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http://dx.doi.org/10.1016/j.jmii.2013Background: Acute otitis media (AOM) is one of the most frequent bacterial infections in chil-
dren. Streptococcus pneumoniae and nontypeable Haemophilus influenzae (NTHi) are the two
major bacterial pathogens. Pneumococcal conjugate vaccine was introduced into Taiwan in
2005 and only some children were vaccinated. This retrospective study assessed the bacterial
etiology of AOM and its antimicrobial susceptibility in the era prior to universal pneumococcal
vaccination in Taiwan.
Methods: From December 2009 to November 2011, children presenting with AOM and having a
middle ear effusion sample collected by tympanocentesis were enrolled. The study period was
divided into two parts. Demographic data of patients and antibiotic susceptibility of the path-
ogens were collected and analyzed. Serotypes of S. pneumoniae were identified.
Results: Among the 151 episodes, 46% of samples found bacterial pathogens. S. pneumoniae
and NTHi were the leading causes of AOM, detected in 55.7% and 22.9% of bacterial AOM ep-
isodes, respectively. The prevalent serotypes of S. pneumoniae were 19 A and 19 F.t of Pediatrics, Mackay Memorial Hospital, Number 92, Section 2, Chung-Shan North Road, Taipei,
h.org.tw (H. Chi).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
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240 Y.-H. Kung et al.Significantly more pneumococcal and serotype 19 A AOM were found in the later study period
(18.4% vs. 33.3%, p Z 0.0036; 10.5% vs. 24.0%, p Z 0.028). Among the 39 S. pneumoniae iso-
lates, 11 strains (28.2%) were penicillin-susceptible. Of the 16 NTHi, 10 (62.5%) were suscep-
tible to amoxicillin/clavulanate and all were susceptible to cefotaxime.
Conclusion: S. pneumoniae and NTHi were the leading causes of AOM in Taiwanese children in
the study period. An increase in patient numbers and proportion of pneumococcal and sero-
type 19 A AOM occurred. Antimicrobial nonsusceptibility was common in the predominant
pathogens.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Acute otitis media (AOM) is one of the most frequently
encountered bacterial infections in children worldwide.
The peak incidence of AOM is in the first 2 years of life,
often between 6 months and 18 months of age.1 Up to 80%
of children experienced at least one episode of otitis media
prior to age 3 years.2 AOM is also the major cause for
physician visits and the most common reason for antibiotic
prescriptions in children.2e5 Streptococcus pneumoniae and
nontypeable Haemophilus influenzae (NTHi) are the two
major bacterial pathogens of AOM worldwide.6,7 Similar
common causes of AOM were found in a previous study in
Taiwan.8
The seven-valent pneumococcal conjugate vaccine
(PCV7; Prevenar, Pfizer/Wyeth, New York) has been avail-
able as self-paid vaccine in Taiwan since October 2005. The
10-valent pneumococcal H. influenzae protein D conjugate
vaccine (PHiD-CV; Synflorix, GlaxoSmithKline Biologicals,
Belgium) was marketed in Taiwan in April 2010. The
13-valent pneumococcal conjugate vaccine (PCV13; Pre-
venar 13, Pfizer/Wyeth, New York) was marketed in Taiwan
in April 2011. The publicly funded pneumococcal vaccine is
only for high-risk groups from July 2009. The high-risk
groups included children younger than 5 years with
impaired splenic function, congenital or acquired immune
deficiency, implantation or replacement of cochlear pros-
thetic device, chronic disease (chronic kidney, heart, or
pulmonary disease and diabetes mellitus), cerebrospinal
fluid leakage, malignancy and post-transplantation. The
pneumococcal vaccinations for children aged 2 years to 5
years have been included in Taiwan’s national immuniza-
tion program since March 2013.
Information on the leading pathogens of AOM and their
antibiotic susceptibility may influence empirical antibiotic
choice and treatment outcome. Concerning the coverage
rate of pneumococcal vaccines, the distribution of pneu-
mococcal serotypes is also important. Therefore, we con-
ducted this study to investigate bacterial etiology including
antimicrobial susceptibility and serotypes of S. pneumoniae
that cause AOM in the era prior to universal pneumococcal
vaccination in Taiwan.
Materials and methods
This retrospective study was approved by the institutional
review board of Mackay Memorial Hospital. We collectedmiddle ear fluid (MEF) samples that were cultured at
Mackay Memorial Hospital (MMH) from December 2009 to
November 2011. The samples were obtained from children
in whom AOM was diagnosed and a tympanocentesis pro-
cedure was performed. AOM was diagnosed by a pediatri-
cian or otolaryngologist after otoscopic examination of the
ear drum, and they decided whether patients needed
tympanocentesis. The procedure was performed by an
otolaryngologist. The MEF sample obtained by tympano-
centesis was immediately applied onto a sterile swab pre-
served in transport medium (Amies Agar Gel-With Charcoal,
COPAN Italia Inc., Brescia, Italy) and was sent for culture at
a clinical microbiology laboratory. The samples were
cultured in sheep blood agar and chocolate agar that was
incubated aerobically at 35 C for 48 hours. Isolation of
bacterial pathogens and determination of antimicrobial
susceptibility profiles were done. The antimicrobial sus-
ceptibility test was performed according to the reference
guidelines in the laboratory in MMH. Susceptibility testing
of antibiotic agents for S. pneumoniae was determined by
the minimum inhibitory concentration (MIC) using Vitek 2
(bioMe´rieux Inc., Hazelwood, MO, USA). Definitions of
antimicrobial susceptibility were based on the Clinical and
Laboratory Antimicrobial Standards Institute (CLSI) 2009
criteria.9 If S. pneumoniae was identified, its serotypes
were also analyzed. Pneumococcal isolates were typed by
the latex agglutination using serotype-specific antisera
(Statens Seruminstitut, Copenhagen, Denmark). In each
patient within one episode, only the result of the first
sample was included. If a patient had more than one
episode of AOM with tympanocentesis during this period,
each episode was analyzed separately.
We reviewed patients’ medical charts and recorded
demographic data, culture results and antibiotic suscepti-
bility test reports, pneumococcal vaccine status, and his-
tory of antibiotic administration in the past 3 months prior
to MEF culture.
Our study period was 24 months, divided into two pe-
riods: from December 2009 to November 2010 and
December 2010 to November 2011. The positive bacterial
culture rates, pneumococcal isolation rates, pneumococcal
serotype distribution, and NTHi-positive rates of the two
periods were compared.
Fisher exact test was performed for categorical vari-
ables. We performed the Mann-Whitney U test for contin-
uous variables. A p < 0.05 was considered statistically
significant. All statistical analyses were performed using
SPSS version 12.0 software (SPSS, Inc., Chicago, IL, USA).
Figure 1. Episode numbers and percentages of bacteria
isolated from middle ear effusion received via tympanocent-
esis in children with acute otitis media.
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We enrolled 151 episodes from 146 patients in whom AOM
was diagnosed and performed tympanocentesis during the
study period. The age of patients was 43.3  30.3 months
(mean  standard deviation), and ranged from 4 months to
213 months. The demographic data is presented in Table 1.
Seventy samples (46.4%) yielded bacteria and two (1.3%)
yielded fungi. Normal flora of the skin accounted for 30
samples (19.9%) and 49 samples (32.5%) yielded no bacterial
or fungi.
Among 70 samples yielding bacteria, the most common
isolated pathogen was S. pneumoniae, which was found in
55.7% of episodes (39 of 70). NTHi was the second common
pathogen, and it accounted for 22.9% of episodes (16 of 70;
Fig. 1). Five serotypes of S. pneumoniae were identified.
The most common serotypes among 39 S. pneumoniae
strains were 19 A (26 strains, 66.7%) and 19 F (7 strains,
17.9%). Two episodes (5.1%) were identified from serotypes
3, 6B, and 14, respectively.
The age distribution of culture-positive episodes was
shown in Fig. 2. S. pneumoniae was the most common iso-
lated bacteria in each age group. There was no NTHi iso-
lated in children older than 5 years.
The enrolled episodes of the earlier and later study
periods were 76 and 75, respectively. S. pneumoniae
accounted for 18.4% (14 of 76) and 33.3% (25 of 75) of AOM
episodes in the two periods, and it had a significantly higher
percentage in the later period (p Z 0.036). The AOM epi-
sodes caused by pneumococcal serotype 19 A were also
significantly increased in the later episode (p Z 0.028;
Fig. 3). However, there was no significant difference in
serotypes 3, 6B, 14, and 19 F between the two periods. No
significant difference of NTHi-positive rates was recorded
between the two periods (9.2% vs. 12%, p Z 0.578).
Among 39 children with 39 episodes of pneumococcal
AOM, only seven (17.9%) had received at least one dose ofTable 1 Demographics of children with acute otitis media
No. of episodes %
Sex
Male 78 51.7
Female 73 48.3
Age (mo)
4e11 12 7.9
12e23 35 23.2
24e35 27 17.9
36e47 18 11.9
48e60 23 15.2
>60 36 23.8
Pneumococcal vaccination
Vaccinated (PCV7) 16 10.6
Vaccinated (PCV10) 1 0.7
Unvaccinated 135 89.4
Previous antibiotic use
within 3 mo
82 54.3
PCV7 Z 7-valent pneumococcal conjugate vaccine;
PCV10 Z 10-valent pneumococcal Haemophilus influenzae
protein D conjugate vaccine.PCV7 prior to their AOM episodes. None of the seven pa-
tients had received PHiD-CV or PCV 13. Five pneumococcal
strains were serotype 19 A and two pneumococcal strains
were serotype 19 F in these seven children.
Eighty-two AOM episodes (54.3%) received antibiotic
treatment within 3 months prior to MEF cultures (Fig. 4). In
this group, 40.2% of episodes yielded bacteria and 40.2%
episodes had no pathogen. In those without previous anti-
biotic use, 53.6% of episodes yielded bacteria and 23.2%
yielded no pathogen. The culture-negative rate of patients
with previous antibiotic therapy was significantly higher
than that of those without previous antibiotic therapy
(pZ 0.036). The bacterial culture-positive rate of patients
with or without antibiotic treatment within 3 months did
not reach statistical significance (p Z 0.106).
Among the 39 isolated S. pneumoniae strains, 28.2% (11
of 39) were found to be susceptible to penicillin, 53.8% (21
of 39) were susceptible to third-generation cephalosporins
(cefotaxime and ceftriaxone) and 97.4% (38/39) to levo-
floxacin. The isolated S. pneumoniae strains were all
resistant to erythromycin (Table 2). Among serotype 19 A
strains, 28.2% (5 of 26) were susceptible to penicillin, 50.0%
(13 of 26) were susceptible to cefotaxime and ceftriaxone,
and 100% to levofloxacin. All 16 NTHi strains were suscep-
tible to cefotaxime and ceftriaxone but only 75.0% (12 ofFigure 2. The age distribution of culture-positive episodes
from children with acute otitis media.
Figure 3. Comparison of the serotypes of S. pneumoniae
identified from children with acute otitis media.
Table 2 Susceptibility of Streptococcus pneumoniae and
Haemophilus influenzae isolates from middle ear effusion
of children with acute otitis media
S. pneumoniae (%) NTHi (%)
Amoxicillin/clavulanate N/A 62.5
Cefotaxime 53.8 100
Ceftriaxone 53.8 100
Cefuroxime N/A 75
Chloramphenicol 94.9 6.8
Erythromycin 0 N/A
Imipenem 15.4 N/A
Levofloxacin 97.4 N/A
Moxifloxacin 100 93.8
Penicillin 28.2 N/A
SXT 12.8 43.8
Vancomycin 100 N/A
NTHi Z non-typeable H. influenzae; N/A Z not available;
SXT Z trimethoprim/sulfamethoxazole.
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NTHi strains (10 of 16) were susceptible to amoxicillin/
clavulanate and 93.8% (15 of 16) were susceptible to
moxifloxacin.
Discussion
In this study we found that S. pneumoniae and NTHi were
still the two leading pathogens of bacterial AOM in the era
prior to universal pneumococcal vaccination in Taiwan, the
same as our previous epidemiological study prior to when
the PCV7 were marketed.8 The other studies conducted in
the United States and Europe also revealed S. pneumoniae
as the most common causative bacteria of AOM in children
prior to pneumococcal vaccination.7,10,11 Block et al10 re-
ported that serotypes 19 F, 3, 23 F, and 6B were the pre-
dominant serotypes in children with pneumococcal AOM in
the United States during the prevaccination era. Hausdorff
et al11 found serotypes 19 F, 23 F, 14, and 6B as major se-
rotypes isolated in their datasets from Finland, France,
Greece, Israel, several East European countries, the United
States, and Argentina. However, serotype 19 A was only
counted at 3.2% and 6.6% of pneumococcal AOM in these
two studies prior to when pneumococcal vaccines were
available.
The pneumococcal conjugate vaccine showed efficacy in
the prevention of AOM caused by the serotypes included inFigure 4. The culture-positive rate of patients with or
without antibiotic treatment in the previous 3 months.the vaccine.12 Changes of the AOM pathogens was found
after the PCV7 was introduced. In some studies, reduction
in pneumococcal AOM and increase in NTHi were
noted,13e16 including our previous data.17 NTHi even once
became the predominance pathogen in the United States.13
A later study in Mexico showed the incidence of bacterial
AOM caused by S. pneumoniae elevated again and was
almost equal to NTHi.18 It was suggested that this should be
the result from the increasing of non-PCV7 serotypes. Our
study revealed a different situation; the S. pneumoniae
culture-positive rate was much higher than NTHi. The
nasopharyngeal carriage rate of H. influenzae type B was
low in Taiwan both prior to and after pneumococcal
vaccination.19,20 AOM caused by NTHi was less in Taiwan
compared with other countries.8 Even vaccine-covered se-
rotypes decreased, but pneumococcal AOM were still more
common than NTHi AOM.
Among pneumococcal AOM, the most frequent isolated
serotypes were 19 A and 19 F in our study. We compared the
former and the later study periods and found significantly
increased pneumococcal AOM, especially serotype 19 A.
Although the prevalent pneumococcal serotypes varied in
different geographical areas, pneumococcal vaccination
could influence serotype distribution.21 Pichichero and
Casey22 reported changes in otopathogens that the non-
PVC7 serotypes S. pneumoniae increased in isolation
from children with AOM. The non-PVC7 serotypes causing
invasive pneumococcal disease (IPD) also increased
worldwide.23e26 Seven patients in this study received at
least one dose of PCV7 prior to their MEF cultures, and five
of them yielded PCV7 noncontained serotype 19 A. Hsieh
et al27 conducted a study after PCV7 vaccination in Taiwan
issued the importance of serotype 19 A in IPD and found the
peak age of disease among children was 2e4 years. In
January 2011, a Taiwan epidemiology bulletin revealed the
increased number of IPD and serotype 19 A epidemic.28 Our
results suggested that an increase in serotype 19 A not only
occurs in IPD, but also in less invasive diseases, just like
AOM.
Etiology of AOM in Taiwanese children 243Two children in our study who received PCV7 previously
got 19 F pneumococcal AOM even though serotype 19 F was
included in PCV7. The immunogenicity of pneumococcal
serotypes is variable after vaccination. In general, the
higher antibody concentration provided better protection
from disease. However, the studies have shown that this
association for serotype 19 F is weak.29 Even high antibody
levels against 19 F do not seem to protect against AOM
caused by 19 F.30 This finding might explain why two pa-
tients experienced 19 F pneumococcal AOM after accep-
tance of PCV7.
In our previous study, only 4.2% of AOM S. pneumoniae
strains were penicillin-susceptible in the 1990s.8 The
penicillin-susceptible S. pneumoniae increased to 28.2%
in this study. However, the CLSI published new S. pneumo-
niae breakpoints for penicillin in 2008. Under the
former criteria, susceptible MIC breakpoint for penicillin was
0.06 mg/mL. The new susceptible MIC breakpoint for non-
meningitis patients who are treated with intravenous peni-
cillin is 2 mg/mL. It might not be reasonable to compare
these two penicillin-susceptible rates of S. pneumoniae.
However, Tsai et al31 reported a transient decrease in peni-
cillin nonsusceptibility, especially by nonmeningitis criteria
in Taiwan. More than 80% of S. pneumoniae strains were
susceptible to third-generation cephalosporins (cefotaxime
and ceftriaxone) in the 1990s.32 We found susceptibility of
third-generation cephalosporins decreased and only half of
the strains were susceptible in the study. About 80% of NTHi
isolated in our hospital in the 2000s were susceptible to
amoxicillin/clavulanate,17 but this percentage decreased to
62.5% in this study. We need to monitor the resistance con-
dition to adjust empirical antibiotic treatment in the future.
Tympanocentesis is thought to be a reliable diagnostic
method to isolate and confirm the pathogenic bacteria.33
The culture of otorrhea fluid draining from the sponta-
neous perforated eardrum may be contaminated by bac-
teria of the external ear canal or skin unless they are
cleaned prior to swabbing otorrhea fluid. Staphylococcus
aureus may be a contamination of the ear canal skin and
was excluded in previous studies.17,34,35 In this study, our
specimens were all obtained directly from tympanocent-
esis; the isolated S. aureus could be regarded as a true
pathogen and was enrolled. However, the coagulase-
negative staphylococci (CoNS) were thought to be normal
flora of the skin and not true pathogens in this study. In our
previous study, the cultures of MEF were obtained mainly
by myringotomy, which is easily contaminated, and CoNS
occupied 33.1% specimens.8 Because specimens were only
collected by tympanocentesis in this study, the proportion
of normal flora of the skin is lower (19.9%). However,
tympanocentesis is not commonly done in children with
AOM because parents usually do not agree to the proce-
dure. It is often accepted by parents when the patients
have persistent symptoms of AOM after empirical antibiotic
treatment, or impending rupture of bulging ear drums.
Although the isolated bacterial strains by tympanocentesis
would be reliable, they might exclude the mild to moderate
AOM strains. Our results indicate data collected from chil-
dren with moderate to severe AOM.
In conclusion, S. pneumoniae and NTHi were the two
most common pathogens of bacterial AOM in the era prior
to universal pneumococcal vaccination in Taiwan. Non-PCV7 pneumococcal serotypes, especially 19 A, became
predominant. Continuous monitoring of the causative
pathogens is needed. More effective and broad-spectrum
vaccines would be indicated.Conflicts of interest
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